OrbiMed Israel GP Ltd.

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 35% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
OrbiMed Israel GP Ltd.'s trades of Adicet Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
298.33
Quantity 39,805
Value US$1,346,398
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-07 2026-04-07
PrS Proposed sale
39,805
298.33
US$1,346,398 		39,805 298.33 US$1,346,398
2024-09-12 2024-09-12
PrS Proposed sale
88,377
185.83
US$796,561 		88,377 185.83 US$796,561
2023-01-05 2023-01-03
S Sale
83,114 -7.9%
99.31
US$555,203 		83,114 -7.9% 99.31 US$555,203
2023-01-05 2023-01-03
S Sale
266,376 -10.3%
3.34
US$889,696 		266,376 -10.3% 3.34 US$889,696
2020-12-04 2020-12-02
S Sale
103,200 -58.4%
21.60
US$2,229,120 		103,200 -58.4% 21.60 US$2,229,120
2019-05-06 2019-05-02
B Purchase
646,204 +25.5%
3.10
US$2,003,232 		646,204 +25.5% 3.10 US$2,003,232